相关实验视频
Updated: Sep 20, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.1K
不需要等离子素激活和等离子素活性来预防静脉血栓症/血栓塞栓症
Yaqiu Sang1, Marzia Menegatti2, Jennifer A Brody3
1UNC Blood Research Center, Chapel Hill, North Carolina, United States.
Blood
|May 22, 2025
概括
血原激活 (PA) 不会增加静脉血栓塞栓症 (VTE) 的风险. 人类和小鼠的研究表明,抑制或缺乏PA不会导致静脉瘤,这表明PA不能防止血栓形成.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 血原激活 (PA) 减少出血,但其在预防血栓 (血栓形成) 中的作用仍有争议.
- 人们担心降低PA可能会增加静脉血栓塞栓症 (VTE) 的风险.
研究的目的:
- 调查PA系统对VTE的贡献.
- 为了确定抑制或缺乏PA是否会增加静脉瘤风险.
主要方法:
- 从HISTORY注册表中分析了血原缺乏的人类.
- 在野生型,异合体和同合体等等离子素缺乏的小鼠中的静脉血栓形成模型.
- 在体外和体内,使用特兰胺酸 (TXA) 制止PA的药理抑制.
- 对VTE风险和PA通路基因进行全基因组关联研究 (GWAS).
- 在英国生物银行中对等离子体水平的蛋白质组学分析.
主要成果:
- 血原缺乏的人类没有报告未引起的VTE.
- 无论是部分还是完全的等离子素缺乏,都没有改变小鼠的血栓质量或组成.
- 在小鼠中,TXA的使用抑制了等离子体生成,但没有显著改变血栓质量或组成.
- 根据GWAS和英国生物库的数据,PA路径变异或等离子原水平与VTE风险之间没有显著的关联.
结论:
- 在PA系统的乱不会增加人或小鼠的VTE风险.
- 内源性PA系统不太可能是预防VTE的分子机制.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
934
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Venous Thrombosis III: Interprofessional Care
29
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
29
Venous Thrombosis I: Introduction
47
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Formation of the Platelet Plug
7.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.2K
Extrinsic and Intrinsic Pathways of Hemostasis
9.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K

